You just read:

Myovant Sciences Announces Positive Top-line Results from Takeda's Phase 3 Study Evaluating the Efficacy and Safety of Relugolix for the Treatment of Pain Associated with Uterine Fibroids

News provided by

Myovant Sciences

Nov 09, 2017, 08:00 ET